Join us for next session on April 28th at 8 am PT / 11 am ET / 4 pm BST part of our Drug Discovery Webinar Series, where leading experts will explore how Direct to Biology (D2B) approaches are accelerating drug discovery projects using wide range of D2B- compatible high throughput workflows, case studies, bioassays, & chemistries.
𝐓𝐢𝐭𝐥𝐞: Direct-to-Biology: A Contemporary Approach to Accelerate Drug Discovery
𝐌𝐞𝐞𝐭 𝐭𝐡𝐞 𝐒𝐩𝐞𝐚𝐤𝐞𝐫𝐬 :
– Chris Wellaway – Director, Medicinal Chemistry, Drug Discovery at Pharmaron
A medicinal chemist with extensive expertise in PROTACs, molecular glues, phenotypic screening, and machine-learning-enabled discovery.
– 𝐃𝐫. William Farnaby – Principal Investigator, University of Dundee Centre for Targeted Protein Degradation
A principal investigator with an interest in induced-proximity chemistry to address and understand diseases of the central nervous system.
– Joanne Wayne – Associate Director, Drug Discovery at Pharmaron (Moderator)
A drug discovery expert with 25+ years of experience across cellular & molecular biology, targeted protein degradation, and early to clinical drug discovery.